Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, data center, hospitality, healthcare, and life sciences markets... Show more
Ecolab Inc. holds a commanding position in the $152 billion total addressable market (TAM) for water treatment, hygiene, and infection prevention solutions, with an estimated 10% market share across diverse segments including Global Water, Institutional & Specialty, Pest Elimination, and Life Sciences. Its competitive moat is fortified by scale—generating over double the revenue of its nearest rival—along with a direct sales force of 25,000 associates, 11,300 patents, and high customer switching costs due to customized, on-site services. Medium-term, Ecolab is pivoting toward high-growth areas like semiconductors, hyperscale data centers, and pharmaceuticals, leveraging digital tools (Ecolab Digital sales up 24% in Q4 2025) and sustainability expertise to drive innovation and customer retention. This positions the company favorably amid industry shifts toward water circularity and resource efficiency.
The Q1 2026 earnings release on April 28 will be pivotal, with analysts forecasting EPS of $1.70 and revenue of $4.03 billion; beats could affirm accelerating growth in high-tech and Life Sciences while clarifying Institutional segment normalization. The CoolIT Systems acquisition, valued at $4.75 billion, enhances Ecolab's end-to-end offerings for AI data centers, potentially boosting high-margin revenue upon Q3 closure. Ongoing "One Ecolab" productivity program targets $325 million in annualized savings by 2027, supporting 100-150 basis points of operating margin expansion. Analyst sentiment remains constructive, with recent upgrades (e.g., BofA raising PT to $345) and a consensus "Buy" from 20+ firms, though some revisions reflect caution on industrial demand. These events could shape investor views on execution amid growth engines' momentum.
Ecolab's trajectory is buoyed by surging demand for ultra-pure water and cooling in AI data centers and semiconductors, alongside regulatory tailwinds for sustainability and hygiene in food, healthcare, and manufacturing. The company's business model benefits from resilient essential services, but remains sensitive to industrial capex cycles, commodity input costs (e.g., chemicals), and inflation, which it counters via pricing actions. Elevated interest rates could temper customer investments in basic industries like paper and power, yet growth segments like Life Sciences show double-digit potential. Geopolitical tensions impacting energy prices add volatility, but Ecolab's global diversification across 170+ countries and digital analytics provide buffers.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it includes searchable prediction categories, historical context, and alert-oriented functionality for timely insights. Visit the Trend Prediction Engine to enhance your market analysis.
For 2026, Ecolab anticipates robust execution with 3-4% organic growth accelerating through the year, 14-16% adjusted operating income growth, and EPS expansion to $8.43-$8.63, aligning closely with analyst estimates of $8.44. Long-term themes include market expansion in AI-driven data centers via CoolIT and Ovivo integrations, sustained margin gains from productivity and pricing, and digital transformation (Ecolab Digital). Competitive threats from smaller players are limited by Ecolab's scale, while regulatory pushes for water efficiency and ESG (environmental, social, governance) compliance favor its portfolio. Capital allocation prioritizes bolt-on M&A (mergers and acquisitions), share repurchases, and dividends, with consensus price targets averaging $322 signaling optimism on these drivers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a developer of cleaning, sanitizing, pest control, maintenance and repair products and services
Industry ChemicalsSpecialty
A.I.dvisor indicates that over the last year, ECL has been loosely correlated with PPG. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ECL jumps, then PPG could also see price increases.
The 10-day moving average for ECL crossed bullishly above the 50-day moving average on June 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on ECL as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ECL just turned positive on May 22, 2026. Looking at past instances where ECL's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
ECL moved above its 50-day moving average on June 11, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ECL advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 284 cases where ECL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ECL broke above its upper Bollinger Band on June 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ECL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.576) is normal, around the industry mean (7.510). P/E Ratio (36.447) is within average values for comparable stocks, (43.938). Projected Growth (PEG Ratio) (2.493) is also within normal values, averaging (72.226). Dividend Yield (0.010) settles around the average of (0.021) among similar stocks. P/S Ratio (4.662) is also within normal values, averaging (93.443).